Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*

Critical Care Medicine
Timothy P HanrahanJason A Roberts


To evaluate the influence of vancomycin dose, serum trough concentration, and dosing strategy on the evolution of acute kidney injury in critically ill patients. Retrospective, single-center, observational study. University Hospital ICU, Birmingham, UK. All critically ill patients receiving vancomycin from December 1, 2004, to August 31, 2009. None. The prevalence of new onset nephrotoxicity was reported using Risk, Injury, Failure, Loss, End-stage renal disease criteria, and independent factors predictive of nephrotoxicity were identified using logistic regression analysis. Complete data were available for 1,430 patients. Concomitant vasoactive therapy (odds ratio = 1.633; p < 0.001), median serum vancomycin (odds ratio = 1.112; p < 0.001), and duration of therapy (odds ratio = 1.041; p ≤ 0.001) were significant positive predictors of nephrotoxicity. Intermittent infusion was associated with a significantly greater risk of nephrotoxicity than continuous infusion (odds ratio = 8.204; p ≤ 0.001). In a large dataset, higher serum vancomycin concentrations and greater duration of therapy are independently associated with increased odds of nephrotoxicity. Furthermore, continuous infusion is associated with a decreased likelihood of...Continue Reading


May 6, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A CovicM Covic
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin P HowdenM Lindsay Grayson
Jul 24, 2004·Journal of Clinical Pharmacy and Therapeutics·A VuagnatL Bernard
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
Jan 21, 2006·Critical Care Medicine·Jean-Louis VincentUNKNOWN Sepsis Occurrence in Acutely Ill Patients Investigators
Feb 8, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M D Kitzis, F W Goldstein
Oct 25, 2006·Archives of Internal Medicine·Levita K HidayatAnnie Wong-Beringer
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Jan 30, 2008·Antimicrobial Agents and Chemotherapy·Thomas P LodiseG L Drusano
Dec 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michael RybakDonald P Levine
Dec 3, 2009·JAMA : the Journal of the American Medical Association·Jean-Louis VincentUNKNOWN EPIC II Group of Investigators
Dec 7, 2010·International Journal of Antimicrobial Agents·Annie Wong-BeringerPaul Beringer
Dec 25, 2010·The American Journal of Medicine·Lindsey PritchardK Bruce Bayley
Mar 16, 2011·Antimicrobial Agents and Chemotherapy·Jason A RobertsJeffrey Lipman
Jul 30, 2011·International Journal of Antimicrobial Agents·Håkan HanbergerUNKNOWN EPIC II Group of Investigators
Oct 12, 2011·Current Opinion in Critical Care·Pleun J van DuijnEvelien A N Oostdijk
Oct 27, 2011·The Journal of Antimicrobial Chemotherapy·Maria Adriana CataldoNicola Petrosillo
Apr 19, 2013·Journal of Medical Case Reports·Silvia RosatiFabrizio Palmieri

❮ Previous
Next ❯


Aug 5, 2015·Journal of Critical Care·Lisa T HongTyree H Kiser
Sep 15, 2016·Medizinische Klinik, Intensivmedizin und Notfallmedizin·A BrinkmannO R Frey
Nov 30, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Abhisekh Sinha RayAlan S L Yu
Nov 30, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Thomas D Nolin
May 6, 2017·Clinical Pharmacology and Therapeutics·E J FilipponeJ L Farber
Jan 23, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·J Nicholas O'DonnellMarc H Scheetz
Feb 14, 2017·Medicina intensiva·S Mas-FontUNKNOWN on belhaf of the Workgroup on Nephrology Intensive Care of the SEMICYUC
Apr 5, 2017·BMC Nephrology·Linda Awdishu, Ravindra L Mehta
Apr 3, 2018·British Journal of Clinical Pharmacology·Kun-Ming PanQian-Zhou Lv
Nov 1, 2017·Antimicrobial Agents and Chemotherapy·Evan J ZasowskiMichael J Rybak
May 1, 2018·Nephron·Juan Carlos Q VelezGautam M Phadke
Feb 10, 2016·Antimicrobial Agents and Chemotherapy·Rocío ÁlvarezJerónimo Pachón
Oct 4, 2018·PloS One·Brady S MoffettAyse Akcan-Arikan
Feb 5, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Doaa M AljefriMarc H Scheetz
Aug 30, 2019·The Journal of Trauma and Acute Care Surgery·Ruben D VillanuevaRyan Kennedy
Apr 3, 2016·Critical Care Nurse·Molly E DroegeEric W Mueller
Jan 7, 2020·The Journal of Antimicrobial Chemotherapy·Frederico Carlos de Sousa Arnaud, Alexandre Braga Libório
Nov 18, 2014·Critical Care Medicine·Verônica T Costa e SilvaEmmanuel A Burdmann
Apr 16, 2015·Critical Care Medicine·Alexander H Flannery, Harrison Bachmeier
Aug 15, 2015·Critical Care Medicine·Denise J van VessemReinier M van Hest
Mar 2, 2016·Therapeutic Drug Monitoring·Erik M van MaarseveenArthur R H van Zanten
Apr 16, 2015·Critical Care Medicine·Timothy P HanrahanJason A Roberts
May 18, 2020·The Journal of Antimicrobial Chemotherapy·Ioannis BellosVasilios Pergialiotis
Mar 30, 2017·Pathogens and Global Health·Douglas de Sousa SoaresElizabeth De Francesco Daher
Apr 9, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Heather L Girand
Apr 15, 2017·Intensive Care Medicine·T TängdénUNKNOWN Infection Section for the European Society of Intensive Care Medicine, the Pharmacokinetics and Pharmacodynamics Study Group
Feb 28, 2019·Journal of Pharmacy Practice·William B Hays, Emma Tillman
Sep 6, 2019·PloS One·Claudmeire Dias Carneiro de AlmeidaMaria Auxiliadora Parreiras Martins
Feb 6, 2019·Antimicrobial Resistance and Infection Control·Ursula Patricia HebeisenNiccolò Buetti
Jun 18, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Vanessa HuffmanJayesh Parmar
Jun 12, 2020·European Journal of Hospital Pharmacy. Science and Practice·Yulin WangYin Deng

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of the Medical Sciences
Sireesha KoppulaHarold M Szerlip
© 2022 Meta ULC. All rights reserved